Conference Coverage

Getting high heightens stroke, arrhythmia risks


 

REPORTING FROM AHA 2019

Arrhythmias study

Dr. Rikinkumar S. Patel of Griffin Memorial Hospital in Norman, Okla. Courtesy Griffin Memorial Hospital

Dr. Rikinkumar S. Patel

Based on recent studies suggesting that cannabis use may trigger cardiovascular events, Dr. Patel and colleagues studied whether cannabis use disorder may be related to arrhythmias, approaching the question through hospital records.

“The effects of using cannabis are seen within 15 minutes and last for around 3 hours. At lower doses, it is linked to a rapid heartbeat. At higher doses, it is linked to a too-slow heartbeat,” he said in a statement.

Dr. Patel and colleagues conducted a retrospective analysis of the Nationwide Inpatient Sample from 2010-2014, a period during which medical marijuana became legal in several states and recreational marijuana became legal in Colorado and Washington. The sample is a database maintained by the Healthcare Cost and Utilization Project of the U.S. Office of Disease Prevention and Health Promotion.

They identified 570,557 patients aged 15-54 years with a primary diagnosis of arrhythmia, and compared them with a sample of 67,662,082 patients hospitalized with no arrhythmia diagnosed during the same period.

They found a 2.6% incidence of cannabis use disorder among patients hospitalized for arrhythmias. Patients with cannabis use disorder tended to be younger (15- to 24-years-old; OR, 4.23), male (OR, 1.70) and African American (OR, 2.70).

In regression analysis adjusted for demographics and comorbidities, cannabis use disorder was associated with higher odds of arrhythmia hospitalization in young patients, at 1.28 times among 15- to 24-year-olds (95% confidence interval, 1.229-1.346) and 1.52 times for 25- to 34-year-olds (95% CI, 1.469-1.578).

“As medical and recreational cannabis is legalized in many states, it is important to know the difference between therapeutic cannabis dosing for medical purposes and the consequences of cannabis abuse. We urgently need additional research to understand these issues,” Dr. Patel said.

“It’s not proving that there’s a direct link, but it’s raising a suggestion in an observational analysis that [this] indeed might be the case. What that means for clinicians is that, if you’re seeing a patient who is presenting with a symptomatic arrhythmia, adding cannabis usage to your list of questions as you begin to try to understand possible precipitating factors for this arrhythmia seems to be a reasonable thing to do,” Dr. Harrington commented.

Pages

Recommended Reading

AASM hypopnea definition best for detecting OSA cases, study finds
MDedge Neurology
Asthma hospitalization in kids linked with doubled migraine incidence
MDedge Neurology
Guideline: Blood CO2 can be used to screen for OHS
MDedge Neurology
Dysregulated sleep is common in children with eosinophilic esophagitis
MDedge Neurology
ACIP approves 2020 adult vaccination schedule
MDedge Neurology
ACIP approves child and adolescent vaccination schedule for 2020
MDedge Neurology
Adolescent lung inflammation may trigger later MS
MDedge Neurology
Thromboembolic events more likely among CIDP patients with CVAD
MDedge Neurology
Brain abscess with lung infection? Think Nocardia
MDedge Neurology
U.S. deaths from preventable causes occur more often in rural areas
MDedge Neurology